Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4045/tidsskr.19.0109 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reporting interhospital neonatal intensive care transport: international five-step Delphi-based template.
BMJ Paediatr Open
April 2024
Norwegian Air Ambulance Foundation, Oslo, Norway.
Objective: To develop a general and internationally applicable template of data variables for reporting interhospital neonatal intensive care transports.
Design: A five-step Delphi method.
Setting: A group of experts was guided through a formal consensus process using email.
Variation in antibiotic consumption in very preterm infants-a 10 year population-based study.
J Antimicrob Chemother
January 2024
Department of Paediatrics and Adolescent Medicine, University Hospital of North Norway, Tromsø, Norway.
Objectives: Wide variations in antibiotic use in very preterm infants have been reported across centres despite similar rates of infection. We describe 10 year trends in use of antibiotics and regional variations among very preterm infants in Norway.
Patients And Methods: All live-born very preterm infants (<32 weeks gestation) admitted to any neonatal unit in Norway during 2009-18 were included.
Late-onset sepsis in very preterm infants in Norway in 2009-2018: a population-based study.
Arch Dis Child Fetal Neonatal Ed
September 2023
Department of Paediatrics, University Hospital of North Norway, Tromso, Norway
Objective: To evaluate epidemiology and outcomes among very preterm infants (<32 weeks' gestation) with culture-positive and culture-negative late-onset sepsis (LOS).
Design: Cohort study using a nationwide, population-based registry.
Setting: 21 neonatal units in Norway.
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.
Front Immunol
October 2021
Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Haploidentical stem cell transplantation (haplo SCT) in Stage IV neuroblastoma relapsed patients has been proven efficacious, while immunotherapy utilizing the anti-GD2 antibody dinutuximab beta has become a standard treatment for neuroblastoma. The combinatorial therapy of haplo SCT and dinutuximab may potentiate the efficacy of the immunotherapy. To gain further understanding of the synergistic effects, functional immunomonitoring was assessed during the clinical trial CH14.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!